What is MOSS?
MOSS Inc. is a specialized manufacturer with over 34 years of experience in producing high-quality, liquid-stable immunoassay reagents, including essential substrates and conjugates. The company serves the diagnostics, pharmaceutical, biotechnology, and veterinary diagnostic industries, focusing on bulk manufacturing and custom services. MOSS Inc. is recognized for its commitment to exceptional sensitivity and lot-to-lot consistency, with products designed for long-term stability of over 36 months. Operating under ISO-9001-2015 guidelines, MOSS Inc. supplies its products to leading manufacturers and select distributors globally, catering to individual customer needs from assay development through to full-scale production.
How much funding has MOSS raised?
MOSS has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for MOSS?
The recent major strategic investment signals MOSS Inc.'s readiness for accelerated growth and market expansion within the competitive diagnostics and biotechnology landscape. This capital infusion is expected to bolster its bulk manufacturing capabilities and potentially drive further innovation in reagent development. As a company with a long-standing reputation for quality and consistency, this late-stage funding will likely enable MOSS Inc. to solidify its market leadership and explore new strategic partnerships or geographical reach, further enhancing its contribution to the life sciences sector.
See full MOSS company page
